Publicaciones en las que colabora con Alfonso Castro Beiras (62)

2015

  1. Exercise echocardiography and cardiac magnetic resonance imaging to predict outcome in patients with hypertrophic cardiomyopathy

    European Heart Journal Cardiovascular Imaging, Vol. 16, Núm. 4, pp. 423-432

  2. Genetics of cardiomyopathies: Novel perspectives with next generation sequencing

    Current Pharmaceutical Design, Vol. 21, Núm. 4, pp. 418-430

2013

  1. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy

    Circulation Journal, Vol. 77, Núm. 9, pp. 2358-2365

  2. p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient

    Heart Rhythm, Vol. 10, Núm. 2, pp. 264-272

2012

  1. Differences in outcome of heart failure with preserved or depressed systolic function in patients older than 70 years who receive beta blockers

    Revista Espanola de Cardiologia, Vol. 65, Núm. 1, pp. 22-28

  2. Indoleamine, 2-3 dioxygenase activity could be an early marker of graft rejection in heart transplantation

    Transplantation Proceedings

  3. Prognostic value of exercise echocardiography in patients with hypertrophic cardiomyopathy

    Journal of the American Society of Echocardiography, Vol. 25, Núm. 2, pp. 182-189

2011

  1. Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy

    European Heart Journal, Vol. 32, Núm. 2, pp. 177-183

2010

  1. Disease: Cardiomyopathy, hypertrophic

    Human Genetics

  2. Disease: Cardiomyopathy, hypertrophic

    Human Genetics

  3. Efecto de un programa de formación en atención primaria sobre la optimización del tratamiento con bloqueadores beta en pacientes ancianos con insuficiencia cardiaca

    Revista Espanola de Cardiologia, Vol. 63, Núm. 6, pp. 677-685

  4. Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3

    Heart, Vol. 96, Núm. 24, pp. 1980-1984

  5. Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy

    BMC Medical Genetics, Vol. 11, Núm. 1

2009

  1. Gene Expression Profiling for Monitoring Graft Rejection in Heart Transplant Recipients

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2240-2243

  2. Mutación en homocigosis en el gen MYBPC3 asociada a fenotipos severos y alto riesgo de muerte súbita en una familia con miocardiopatía hipertrófica

    Revista Espanola de Cardiologia, Vol. 62, Núm. 5, pp. 572-575

2008

  1. Large scale analysis of HCM mutations in sudden cardiac death

    Forensic Science International: Genetics Supplement Series, Vol. 1, Núm. 1, pp. 549-550

  2. Sudden death in a patient with lamin A/C gene mutation and near normal left ventricular systolic function

    International Journal of Cardiology, Vol. 126, Núm. 1, pp. 136-137

2007

  1. Comparison of 2- and 3-Dimensional Exercise Echocardiography for the Detection of Coronary Artery Disease

    Journal of the American Society of Echocardiography, Vol. 20, Núm. 8, pp. 959-967

  2. Identification of a cardiac allograft rejection marker using microarray gene expression analysis in lymphocytes from heart transplant patients [4]

    Revista Espanola de Cardiologia

  3. Left Ventricular Asynchrony in Patients with Hypertrophic Cardiomyopathy: Its Determinants and its Relation to Left Ventricular Function

    Journal of the American Society of Echocardiography, Vol. 20, Núm. 11, pp. 1247-1252